A Review of Treatment Options Available for Women with Uterine Fibroids

References (89)

1. 1 Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma.
2. 2 Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy [DOI]
3. 3 High-Intensity Focused Ultrasound: Current Potential and Oncologic Applications [DOI]
4. 4 Fibroids and Infertility: A Systematic Review of the Evidence [DOI]
5. 5 Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids [DOI]
6. 6 Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images [DOI]
7. 7 Vitamin D and the Risk of Uterine Fibroids [DOI]
8. 8 Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy [DOI]
9. 9 Systematic Review of Mifepristone for the Treatment of Uterine Leiomyomata [DOI]
10. 10 Fertility after hysteroscopic myomectomy [DOI]
11. 11 Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study [DOI]
12. 12 RETRACTED: Submucous myomas and their implications in the pregnancy rates of patients with otherwise unexplained primary infertility undergoing hysteroscopic myomectomy: a randomized matched control study [DOI]
13. 13 Regression of uterine leiomyomata in response to the antiprogesterone RU 486 [DOI]
14. 14 The Maine Womenʼs Health Study [DOI]
15. 15 Laparoscopic Versus Open Myomectomy: A Double-Blind Study to Evaluate Postoperative Pain [DOI]
16. 16 Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas [DOI]
17. 17 Modern management of uterine fibroids [DOI]
18. 18 Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice [DOI]
19. 19 Traditional Surgical Approaches to Uterine Fibroids: Abdominal Myomectomy and Hysterectomy [DOI]
20. 20 The effect of a levonorgestrel-releasing intrauterine device in the treatment of myoma-related menorrhagia [DOI]
21. 21 Selective estrogen receptor modulators (SERMs) for uterine leiomyomas [DOI]
22. 22 Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells [DOI]
23. 23 Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix [DOI]
24. 24 Image-Guided Thermal Therapy of Uterine Fibroids [DOI]
25. 25 Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: early clinical experience [DOI]
26. 26 Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas [DOI]
27. 27 Ultrasound-Guided Radiofrequency Thermal Ablation of Uterine Fibroids: Medium-Term Follow-Up [DOI]
28. 28 Percutaneous Sonographically Guided Radiofrequency Ablation of Medium-Sized Fibroids: Feasibility Study [DOI]
29. 29 An image‐guided high intensity focused ultrasound device for uterine fibroids treatment [DOI]
30. 30 The gynecologic contribution to intestinal obstruction in females.
31. 31 Role of Hormonal and Reproductive Factors in the Etiology and Treatment of Uterine Leiomyoma [DOI]
32. 32 Regression of Uterine Leiomyomata in Response to the Antiprogesterone RU 486 [DOI]
33. 33 GnRH agonists and uterine leiomyomas [DOI]
34. 34 Pharmacotherapeutic Effects of Kuei-chih-fu-ling-wan (Keishi-bukuryo-gan) on Human Uterine Myomas [DOI]
35. 35 A comparison of laparoscopic supracervical hysterectomy and total abdominal hysterectomy outcomes [DOI]
36. 36 Transvaginal radiofrequency thermal ablation: A day‐care approach to symptomatic uterine myomas [DOI]
37. 37 Magnetic Resonance-Guided Percutaneous Cryoablation of Uterine Fibroids: Early Clinical Experiences [DOI]
38. 38 Laparoscopic Ultrasound-Guided Radiofrequency Ablation of Uterine Fibroids [DOI]
39. 39 Ulipristal Acetate [DOI]
40. 40 [Low-dose combination oral contraceptives use in women with uterine leiomyomas].
41. 41 GnRH agonists before surgery for uterine leiomyomas. A review.
42. 42 Short-Term Treatment of Uterine Fibromyomas with Danazol [DOI]
43. 43 Prospective randomised trial comparing gonadotrophin‐releasing hormone analogues with triple tourniquets at open myomectomy [DOI]
44. 44 Bone Mass Reduction after Estrogen Deprivation by Long-Acting Gonadotropin-Releasing Hormone Agonists and Its Relation to Pretreatment Serum Concentrations of 1,25-Dihydroxyvitamin D3 [DOI]
45. 45 Mr image‐guided control of cryosurgery [DOI]
46. 46 What is the place of uterine artery embolisation in the management of symptomatic uterine fibroids? [DOI]
47. 47 Uterine artery ligation for the treatment of fibroids [DOI]
48. 48 Advances in the management of uterine fibroids [DOI]
49. 49 Hysteroscopic endometrial ablation without endometrial preparation [DOI]
50. 50 Hysterectomies Amongst Teenagers in Calabar, Nigeria [DOI]
51. 51 Fibroids and infertility: an updated systematic review of the evidence [DOI]
52. 52 Etiology, symptomatology, and diagnosis of uterine myomas [DOI]
53. 53 Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up [DOI]
54. 54 Complications of hysteroscopy: a prospective, multicenter study [DOI]
55. 55 Vitamin D and African Americans [DOI]
56. 56 Growth of uterine leiomyomata among premenopausal black and white women [DOI]
57. 57 Pregnancy After Uterine Artery Embolization for Leiomyomata: [DOI]
58. 58 Hysteroscopic myomectomy: a comprehensive review of surgical techniques [DOI]
59. 59 Uterine Fibroids: Uterine Artery Embolization versus Abdominal Hysterectomy for Treatment—A Prospective, Randomized, and Controlled Clinical Trial [DOI]
60. 60 Complications of hysteroscopic surgery: predicting patients at risk [DOI]
61. 61 Low-Dose Mifepristone for Uterine Leiomyomata [DOI]
62. 62 Protective effect of depot‐medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case‐control study [DOI]
63. 63 Medical management of fibroids [DOI]
64. 64 Fundamental Neurological Research and Human Neurosurgery Using Intense Ultrasound [DOI]
65. 65 ACOG Committee Opinion #293: Uterine Artery Embolization [DOI]
66. 66 Gonadotrophin-Releasing Hormone and Magnetic-Resonance–Guided Ultrasound Surgery for Uterine Leiomyomata [DOI]
67. 67 Early outcome of myomectomy by laparotomy, minilaparotomy and laparoscopically assisted minilaparotomy. A randomized prospective study [DOI]
68. 68 Transvaginal ultrasound-guided radiofrequency myolysis for uterine myomas [DOI]
69. 69 Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study [DOI]
70. 70 Gestrinone in the treatment of uterine leiomyomata: Effects on uterine blood supply [DOI]
71. 71 Obstetrics and Gynaecology - an Evidence Based Text for Mrcog
72. 72 A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
73. 73 Role of leuprolide acetate depot in hysteroscopic surgery: a controlled study [DOI]
74. 74 Does Low-Dose Combination Oral Contraceptive Use Affect Uterine Size or Menstrual Flow in Premenopausal Women With Leiomyomas? [DOI]
75. 75 Complementary medicine treatment of uterine fibroids: a pilot study.
76. 76 Myoma coagulation (myolysis) [DOI]
77. 77 Ulipristal acetate in uterine fibroids [DOI]
78. 78 Reproductive outcome after laparoscopic myomectomy in infertile women.
79. 79 Myomectomy and MRI-Directed Cryotherapy [DOI]
80. 80 Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice [DOI]
81. 81 Mifepristone: Clinical Application in General Gynecology [DOI]
82. 82 Uterine artery embolisation for symptomatic fibroids [DOI]
83. 83 Uterine Artery Embolization Versus Hysterectomy in the Treatment of Symptomatic Uterine Fibroids: 10 Years’ Outcomes From the Randomized EMMY Trial [DOI]
84. 84 Does Low-Dose Combination Oral Contraceptive Use Affect Uterine Size or Menstrual Flow in Premenopausal Women With Leiomyomas? [DOI]
85. 85 Expectant and medical management of uterine fibroids [DOI]
86. 86 Update on Management of Uterine Fibroid
87. 87 The cochrane database of systematic reviews [DOI]
88. 88 Protective effect of depot‐medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case‐control study [DOI]
89. 89 Selective estrogen receptor modulators (SERMs) for uterine leiomyomas [DOI]

Cited by 6

Showing 3 of 6 known citations — external sources report more than can currently be individually listed.

Related research

• Pattern of Hearing Impairment in a Tertiary Institution in Ado Ekiti, Nigeria — shares topic coverage
• Weight Gain as Tuberculosis Treatment Regimen Progresses in Patients Receiving Antituberculosis Therapy — shares topic coverage
• TREAT-B has Good Accuracy in Selecting HBV Infected Patients for Treatment in Sudan — shares topic coverage
• Botox Treatment: A Comprehensive Review — shares topic coverage
• Harnessing Artificial Intelligence in Healthcare Analytics: From Diagnosis to Treatment Optimization — shares topic coverage